Navigation Links
NeuroQuant®, CorTechs Labs' FDA-Cleared System for Quantifying Regional Brain Atrophy from MRIs, Used to Identify Patients at Highest Risk for Developing Dementia
Date:10/12/2011

LA JOLLA, Calif., Oct. 12, 2011 /PRNewswire/ -- A ground-breaking paper published online today (Heister, Brewer, Magda, Blennow & McEvoy, for the Alzheimer's Disease Neuroimaging Initiative, 2011, Predicting MCI Outcome with Clinically Available MRI and CSF Biomarkers, Neurology, epub ahead of print) compared the ability of three clinically available measures to predict the onset of dementia: i) degree of memory impairment,  ii) degree of atrophy in the medial temporal lobe of the brain as measured by NeuroQuant®, and iii) levels of peptides in cerebrospinal fluid that are associated with Alzheimer's disease.  It reported that quantitative atrophy measurement significantly improved prediction of future dementia onset in elderly individuals with memory complaints.

According to Dr. Linda McEvoy, from the Department of Radiology at the University of California, San Diego (UCSD) and senior author of the report: "When these risk factors were examined separately, individuals positive on any one risk factor showed higher risk of developing dementia than individuals testing negative on that factor. More importantly, the joint presence of any two risk factors substantially increased risk. In fact 85% of patients with both higher memory impairment and medial temporal atrophy became demented within 3 years, whereas only 5% of those testing negative on both criteria did. Of the three measures, the presence of atrophy predicted the fastest rate of decline."

Dr. James Brewer, another study co-author who is a neurologist and faculty member at UCSD, indicated that: "Ongoing heart damage can be detected with physical markers, but no such measure has existed for brain degeneration. This paper shows that we now can look directly at the brain using MRI and NeuroQuant® to determine if critical structures are degenerating. At UCSD, we have been using this tool clinically for more than three years and it has fundamentally changed the way that patients are assessed and managed. In individuals without neurodegeneration, the search for other causes can be curative; in individuals with neurodegeneration, education and preparation is facilitated by the more accurate assessment."

The FDA-cleared NeuroQuant® system is "intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of MR images". Using scans routed from a scanner or PACS as input, it can return age-related statistical atrophy reports and numerical and color-blended anatomical volumes to most DICOM-compliant viewing devices. NeuroQuant® is already available at more than 50 leading clinical sites across the nation.

About CorTechs Labs, Inc.  CorTechs translates advanced neuroimaging research into practical clinical tools that may improve care of the millions of people suffering from neurodegenerative disorders. For more information please visit our website at www.cortechslabs.com.

CONTACT:  CorTechs Labs, Inc. +1 858 459 9700 info@cortechslabs.com


'/>"/>
SOURCE CorTechs Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
2. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
3. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
4. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
5. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
6. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
7. NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection
8. Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
9. GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
10. Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc.
11. GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 26, 2016 Story Highlights: ... models within the health care industry is causing providers ... , Deloitte offers a suite of solutions for ... impacting efficient cost optimization: labor resource analysis, revenue cycle ... facilitate better outcomes and better economics ...
(Date:6/24/2016)...  Collagen Matrix, Inc., ("Collagen Matrix") the driving ... collagen and mineral based medical devices for tissue ... Messer has joined the company as Vice ... growing portfolio of oral surgery, neurosurgery, orthopaedic and ... the Collagen Matrix executive team as an accomplished ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
Breaking Medicine News(10 mins):